Read More Analyst Ratings Initiation News Price Target B. Riley Securities Initiates Coverage On Gain Therapeutics with Buy Rating, Announces Price Target of $21 By Benzinga Newsdesk Today, 2:11 AM B. Riley Securities analyst Mayank Mamtani initiates coverage on Gain Therapeutics (NASDAQ:GANX) with a Buy rating and announces Price Target of $21. GANX
Read More Guidance News Corteva Sees FY23 EPS $2.70-$2.90 Vs $3.13 Est.; FY23 Revenue $18.1B-$18.4B Vs $18.49B Est By Happy Mohamed Today, 2:11 AM 2023 Guidance The outlook for agriculture remains robust in 2023, with record demand for grain and oilseeds as ending stocks continue to be under pressure. Commodity prices are above historical averages, CTVA
Read More Global Government News Biden Team Weighs China Trade Probe In Bid To Pressure Beijing By Michael Horton Today, 2:11 AM -Bloomberg SPY
Read More Federal Reserve News Fed’s Evans Says We Are In A Good Place On Rates, Can Pivot To Be More Restrictive If Needed, Or Not Raise Rates As Much; Says We Are Well Positioned For Turns In The Data Over The Next Couple Of Months By Benzinga Newsdesk Today, 2:11 AM -Reuters SPY